Bringing the fundamentals into focus…
Back to Taysha Gene Therapies, Inc.
How Taysha Gene Therapies, Inc. stacks up
TSHA · against 446 other Healthcare companies of similar size
Profitability
1/ 100
Near the bottom of its peers.
Ranked #441 of 447 · scores higher than 0% of peers
Bars: peers in each 10-point band of the profitability score35 peers with a profitability score of 0–9, including TSHA · Click a bar to see the companies
Why profitability scores 1?
Weighted metrics compared with all Healthcare companies.Mainly because of its operating margin and return on assets, which are weaker than most Healthcare peers.
- a thinner operating margin: weaker than 96% of peers. Operating margin: -2792.3% vs peer median 7.1%
- a lower return on assets: weaker than 87% of peers. Return on assets: -31.8% vs peer median 1.7%
- Return on invested capital is not reported, so it is left out of the score.
Metric by metric
Position: dot = TSHA, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | TSHA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 423 reported | Not reported | 5.3% | — | — | 33% |
| Operating marginHigher is better · 421 reported | -2792.3% | 7.1% | 3% | 33% | |
| Return on assetsHigher is better · 432 reported | -31.8% | 1.9% | 11% | 33% | |
| Return on equityHigher is better · 416 reported | -47.1% | 3.4% | 15% | Context only | |
| Gross marginHigher is better · 465 reported | 100.0% | 47.5% | 97% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by profitability score
Top 5 and the companies ranked around TSHA| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 3 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 3 | 11.2B DKK (≈$1.7B) | 99 | 59 | |
| 3 | 914M USD | 99 | 81 | |
| 441 | 1.8B USD | 1 | 30 | |
| 441 | 1.0B USD | 1 | 32 | |
| 441 | 825M USD | 1 | 24 | |
| 441 | 1.2B USD | 1 | 21 | |
| 441 | 1.3B USD | 1 | 44 | |
| 446 | 1.2B USD | 0 | 6 | |
| 446 | 952M USD | 0 | 3 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score